Competitive Salary: EMBL: Agricultural Genomics and Bioinformatics Team Leader Cambridge, Cambridgeshire, England

Notice NOT-OD-20-173 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-300 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric ?precision therapeutics.

Funding Opportunity PAR-20-299 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage applications that will perform basic, translational and clinical research to (1) advance the understanding of underlying mechanisms of drug action; (2) discover and develop novel therapeutics; (3) enhance the usage of existing drugs or drug repurposing for safer and more effective treatment for pregnant women, lactating women, neonates and children. The overall goal is to improve drug safety and efficacy for maternal and pediatric precision therapeutics.

Notice NOT-NS-20-038 from the NIH Guide for Grants and Contracts

Molecular laboratory and bioinformatic analysis skills. Complete the online application and upload a single PDF file containing a cover letter, CV, academic… $50,000 a year
From University of Wyoming - Fri, 11 Sep 2020 02:15:41 GMT - View all Laramie, WY jobs

Notice NOT-AI-20-071 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-101 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-DK-20-506 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to solicit applications from current USDRN Clinical Centers to complete these clinical investigations.

Funding Opportunity RFA-DK-20-507 from the NIH Guide for Grants and Contracts. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)s Urinary Stone Disease Research Network (USDRN) is conducting a multi-center randomized clinical trial and an observational clinical study to a) provide evidence on the effects of increased fluid intake and urine output on urinary stone disease recurrence through innovative adherence strategies, b) understand and mitigate ureteral stent-associated pain and urinary symptoms, and c) collect data and biological samples for future investigations. The purpose of this Limited Competition Funding Opportunity Announcement (FOA) is to invite applications from the current USDRN Scientific Data Research Center to complete these clinical investigations.

Notice NOT-CA-20-100 from the NIH Guide for Grants and Contracts

Notice NOT-TW-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-172 from the NIH Guide for Grants and Contracts

Notice NOT-OH-20-008 from the NIH Guide for Grants and Contracts

Notice NOT-CA-20-103 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-20-293 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for centers to support transdisciplinary teams of clinical and mental health services researchers, behavioral scientists, social scientists, health information and communications technologists, health systems engineers, decision scientists, and mental health stakeholders (e.g., service users, family members, clinicians, payers) to engage in high-impact studies that will significantly advance clinical practice and generate knowledge that will fuel transformation of mental health care in the United States. Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers will support the rapid development, testing, and refinement of novel and integrative approaches for (1) optimizing the effectiveness of therapeutic or preventive interventions for mental disorders within well-defined target populations; (2) organizing and delivering optimized mental health services within real world treatment settings; and (3) continuously improving the quality, impact, and durability of optimized interventions and service delivery within diverse care systems. The ALACRITY Centers program is intended to support research that maximizes synergies across various components of the mental health research ecosystem, including new discoveries in clinical research, transformative health care technologies, advances in information science, and new federal and state mechanisms for organizing mental health care.

Notice NOT-CA-20-102 from the NIH Guide for Grants and Contracts

Notice NOT-OD-20-170 from the NIH Guide for Grants and Contracts

Notice NOT-MD-20-029 from the NIH Guide for Grants and Contracts

Notice NOT-AI-20-073 from the NIH Guide for Grants and Contracts